分级管理护理联合正念减压干预对乳腺癌患者化疗致呕吐及生活质量的影响

Effect of Graded Management Nursing Combined with Mindfulness Decompression Intervention on Vomiting and Life Quality of Patients with Breast Cancer Caused By Chemotherapy

目的探讨分级管理护理联合正念减压干预对乳腺癌患者化疗引发的呕吐及生活质量的影响。方法选取2018年1月—2022年12月宜兴市人民医院治疗的100例乳腺癌患者作为研究对象,依据数字表法随机分为对照组和观察组。对照组接受常规护理,观察组采用分级管理护理联合正念减压干预。对比两组的不良反应发生率、疲劳程度[Piper疲劳修订量表(PFS-R)]及生活质量[生活质量测定量表(EORTCQLQ-C30)]。结果观察组患者经干预后出现的恶心呕吐情况低于对照组(P<0.05)。干预后,两组患者的疲劳程度、EORTCQLQ-C30评分相较干预前均有显著改善,且观察组各项评分均优于对照组(P<0.05)。结论分级管理护理联合正念减压干预能有效改善并缓解乳腺癌患者化疗时引发的恶心呕吐,同时提高患者的生活质量,具有显著的临床应用价值。

Objective This study aims to explore the effects of tiered management nursing combined with mindfulness-based stress reduction intervention on chemotherapy-induced vomiting and quality of life in breast cancer patients.Methods A total of 100 breast cancer patients treated at Yixing City People's Hospital from January 2018 to December 2022 were selected as subjects for this study.They were randomly divided into a control group and an observation group using a random number table method.The control group received standard nursing care,while the observation group was treated with tiered management nursing combined with mindfulness-based stress reduction intervention.The incidence of adverse reactions,fatigue levels[using the Piper Fatigue Scale-Revised(PFS-R)],and quality of life[measured with the EORTC QLQ-C30]were compared between the two groups.Results Post-intervention,the incidence of nausea and vomiting in the observation group was significantly lower than in the control group(P<0.05).After the intervention,both groups showed significant improvements in fatigue levels and EORTC QLQ-C30 scores compared to before the intervention,with the observation group scoring better than the control group(P<0.05).Conclusion Tiered management nursing combined with mindfulness-based stress reduction intervention can effectively improve and alleviate chemotherapy-induced nausea and vomiting in breast cancer patients,while also enhancing their quality of life,demonstrating significant clinical application value.